Osmotica Pharmaceuticals PLC expected to post a loss of 23  cents a share - Earnings Preview

RVL Pharmaceuticals

07/05/2021 22:44

* Osmotica Pharmaceuticals PLC  OSMT.OQ   OSMT.O  is expected
to show a fall in quarterly revenue when it reports results on
May 10 (estimated) .
* The Bridgewater, New Jersey-based company is expected to
report   a 37.0% decrease in revenue to $30.65 million from
$48.65 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Osmotica
Pharmaceuticals PLC is for a loss of 23 cents per share. For the
same quarter last year, the company reported a loss of 5 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by about 0.6%
in the last three months. ​
* Wall Street's median 12-month price target for Osmotica
Pharmaceuticals PLC is $8​, about 62.9% above​ its last closing
price of $2.97. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.28       -0.24      -0.88     Missed  -271.8
 Sep. 30 2020  -0.20       -0.20      -0.14     Beat    30
 Jun. 30 2020  -0.12       -0.12      -0.22     Missed  -76​
 Mar. 31 2020  -0.15       -0.14      -0.05     Beat    65.1
 Dec.          -0.09​      -0.06      -0.51     Missed  -696.9
 31​ 2019​                                              ​
 Sep. 30 2019  -0.23       -0.20      -2.15     Missed  -961.7
                                                        ​
 Jun. 30 2019  -0.12       -0.14      0.02      Beat    113.8
 Mar. 31 2019  -0.09       -0.05      -0.09     Missed  -63.6
 This summary was machine generated May 7 at 21:44 GMT.  All
figures in US dollars unless otherwise stated